市場調査レポート
商品コード
1629200

子宮内膜アブレーション市場:タイプ別、最終用途別、国別、地域別 - 世界産業分析、市場規模、市場シェア、予測、2025年~2032年

Endometrial Ablation Market, By Type, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032


出版日
ページ情報
英文 303 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
子宮内膜アブレーション市場:タイプ別、最終用途別、国別、地域別 - 世界産業分析、市場規模、市場シェア、予測、2025年~2032年
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

子宮内膜アブレーションの市場規模は、2024年に3億9,860万米ドルとなり、2025年から2032年にかけてCAGR5.80%で拡大すると予想されています。

子宮内膜アブレーション市場 - 市場力学

子宮異常出血(AUB)の増加

子宮内膜異常出血(AUB)の増加率は、子宮内膜アブレーションの世界市場の主要な促進要因です。AUBは女性のQOLを著しく低下させる疾患群で、月経不順や月経量が極端に多いことが特徴です。これには、特にひどい出血や長引く出血である月経困難症、生理中や生理と生理の間の過剰な出血である月経不正出血、生理と生理の間の出血である月経困難症が含まれます。AUB症例の増加には様々な要因が考えられます。ヘルスケアシステムが進歩し、より多くの診断や治療が受けられるようになるにつれ、女性が医師の助言を求めたり、月経の健康問題について知識を深めたりするようになったのは、月経困難に対する認識や認識が高まったことが大きな要因の一つです。AUBの発生率の増加に関連するライフスタイルの変化の中には、ストレスの増加、肥満、生殖に関する健康行動の変化などがあります。

さらに、高齢化もAUB有病率増加の大きな原因です。高齢の女性では、ホルモンの異常により月経不順の頻度が増加します。このことは、AUBの症状を示す女性の数が増加しており、効果的な治療に対する需要が高まっていることを示唆しています。

子宮内膜アブレーション市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2025年~2032年)に約5.80%のCAGRで毎年成長すると推定されます。

タイプセグメンテーションに基づくと、デバイスは2024年に最大の市場シェアを示すと予測されました。

最終用途セグメンテーションに基づくと、2024年には病院が主要セグメントとなりました。

地域別では、北米が2024年に収益を生み出す主要市場となりました。

子宮内膜アブレーション市場 - セグメンテーション分析:

子宮内膜アブレーションの世界市場は、タイプ、最終用途、地域に基づいてセグメント化されます。

タイプベースでは、市場はデバイス(マイクロ波エネルギー、高周波アブレーション、サーマルバルーン、クライオアブレーション、水熱アブレーション、子宮鏡)と手順に分離されます。2024年、市場は装置カテゴリーが支配的でした。バルーン内に加熱した流体を注入して子宮内膜を破砕するバルーン療法、高エネルギーのラジオ波を使って子宮内膜組織を破壊するラジオ波焼灼療法、極低温の流体やクライオプローブと呼ばれる器具を使って異常組織を凍結・破砕する方法など、効率的な方法やツールが数多く利用できるようになったためです。さらに、このセグメントの需要は、追加的な子宮内膜除去装置と比較して、有効性、製品の簡便性、迅速な治療、手頃な価格などの利点に起因するところが大きいです。さらに、医師が子宮内膜除去装置に簡単にアクセスできることが、近い将来の市場セグメントの成長を促進しています。

最終用途に基づき、市場は病院、診療所、外来手術センター(ASCs)、その他に分けられます。2024年には、病院カテゴリーが圧倒的な市場シェアを占めています。この重要性は、婦人科疾患のために入院する人の増加に関連しており、病院の熟練した治療と有利な診療報酬慣行がこれを後押ししています。病院は最先端の治療技術を有しており、これがこのセグメントの成長に寄与しています。さらに、外科手術中に起こりうる合併症への徹底的な対応や、病院内でさまざまな治療オプションが利用できることも、他の医療環境と比較して患者数の増加に寄与しています。

子宮内膜アブレーション市場 - 地理的洞察

2024年には、北米が子宮内膜アブレーションの世界市場で支配的な地位を占めていました。この地域の優位性は、婦人科疾患の有病率の上昇、ヘルスケアインフラの顕著な改善、最先端の子宮内膜アブレーション装置を供給できる重要な産業企業の存在によって後押しされています。米国では、ヘルスケアの質の向上とコスト削減への取り組みが、患者の転帰と安全性への着実な集中によって推進されてきました。同地域のヘルスケア支出は世界の他の地域よりも多く、市場の上昇に拍車をかけています。

さらに、今後数年間、アジア太平洋地域は子宮内膜アブレーション市場において最大のCAGRで拡大すると予測されています。不十分な清潔習慣に起因する月経痛の発生率の上昇や、最先端で洗練された子宮内膜アブレーション装置へのニーズの高まりにより、市場は拡大しています。さらに、有利な政府規制、ヘルスケア産業への投資の増加、不正子宮出血に対する認識の拡大、低侵襲治療に対する受容性の高まりにより、このセグメントは今後数年間で利益を上げる可能性があります。

子宮内膜アブレーション市場 - 競合情勢:

子宮内膜アブレーション市場は競争が激しく、多くの大手企業が婦人科疾患に対する独創的かつ実用的な治療を提供することで市場シェアを争っています。患者の転帰を改善し市場シェアを拡大するため、これらの企業は製品や技術の開拓に注力しています。Smith &Nephew Plc、Johnson &Johnson、Hologic、Olympus Corporation、The Cooper Companies, Inc.、Karl Storz GmbH &Co.KGなどが市場の主要企業です。これらの企業は、製品ラインを拡大し、国際的な足跡を強化するために、パートナーシップ、買収、合併、提携などの戦術を使用しています。例えば、2023年3月、新しい子宮内膜アブレーションツールであるEnSeal Endometrial Ablation SystemがOlympus Corporationによって発表されました。EnSeal Endometrial Ablation Systemと呼ばれるバイポーラ高周波焼灼ツールは、HMBの治療を目的としています。

最近の動向

2023年2月、Hologic Inc.のNovaSure V5 グローバル子宮内膜アブレーション(GEA)がカナダと欧州市場で規制当局の承認を得ました。この革新的な薬剤は、子宮内膜異常出血(AUB)の治療を目的としています。

2023年1月、新規の子宮内膜アブレーション装置であるNovaSureがHologicから発売されました。月経多量出血(HMB)は、高周波焼灼装置であるNovaSureで治療できます。

目次

第1章 子宮内膜アブレーションの市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 子宮内膜アブレーションの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 子宮内膜アブレーション産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 子宮内膜アブレーション市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 子宮内膜アブレーション市場情勢

  • 子宮内膜アブレーション市場シェア分析、2024年
  • 内訳データ:主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 子宮内膜アブレーション市場:タイプ別

  • 概要
    • セグメントシェア分析:タイプ別
    • デバイス
      • マイクロ波エネルギー
      • 高周波アブレーション
      • 熱気球
      • 凍結療法
      • 水熱アブレーション
      • 子宮鏡検査
    • 手順

第8章 子宮内膜アブレーション市場:最終用途別

  • 概要
    • セグメントシェア分析、最終用途別
    • 病院
    • クリニック
    • 外来手術センター(ASC)
    • その他

第9章 子宮内膜アブレーション市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析 - 子宮内膜アブレーション業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Smith & Nephew Plc
    • Johnson & Johnson
    • Hologic
    • Olympus Corporation
    • The Cooper Companies, Inc.
    • Karl Storz GmbH & Co. KG
    • Medtronic Plc
    • Ethicon, LLC.
    • Boston Scientific Corporation
    • Minerva Surgical, Inc.
    • Richard Wolf GmbH
    • その他

第11章 アナリストの全方位展望

目次
Product Code: ANV4483

REPORT HIGHLIGHT

Endometrial Ablation Market size was valued at US$ 398.6 Million in 2024, expanding at a CAGR of 5.80% from 2025 to 2032.

A non-invasive procedure known as "endometrial ablation" involves either destroying or ablation of the endometrium, which is the outermost layer of the uterus. One technique used to manage irregular uterine bleeding is endometrial ablation. Persistent irregular uterine bleeding can also result in anaemia and low blood count. Since endometrial ablation requires no incisions and is preferred by many who experience menstrual problems, it has grown in popularity over time. The global endometrial ablation market is expected to grow as a result of the increasing incidence of cervical cancer, the development of next-generation ablation techniques and technologies, and the growth in the number of hospitals and surgical centres using ablation treatments. On the other hand, market expansion is probably going to be constrained by healthcare cost-cutting measures and an unwelcoming regulatory environment. Furthermore, promising opportunities are anticipated to arise soon as the general public is more aware of the variety of ablation procedures available.

Endometrial Ablation Market- Market Dynamics

Rising cases of abnormal uterine bleeding (AUB)

Increasing rates of abnormal uterine bleeding (AUB) is the key driver of the global market for endometrial ablation. AUB is a group of illnesses that can seriously lower a woman's quality of life and are characterized by irregular or extremely heavy menstrual flow. This includes menorrhagia, which is particularly severe or prolonged bleeding; menometrorrhagia, which is excessive bleeding during and between periods; and metrorrhagia, which is bleeding between periods. A variety of factors could cause the rise in AUB cases. As healthcare systems advance and more diagnoses and treatments are available, one significant factor contributing to the rise in women seeking medical advice and becoming more knowledgeable about menstrual health issues is the greater awareness and identification of menstrual difficulties. Among the lifestyle changes linked to increased incidences of AUB are increased stress, obesity, and changes in reproductive health behaviours.

Additionally, the ageing population is a significant cause of the increasing prevalence of AUB. The frequency of irregular menstruation is increased in older women due to hormonal abnormalities. This suggests that the number of women displaying symptoms of AUB is increasing, which increases the demand for effective treatments.

Endometrial Ablation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2025-2032)

Based on type segmentation, the devices were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Endometrial Ablation Market- Segmentation Analysis:

The Global Endometrial Ablation Market is segmented on the basis of Type, End Use, and Region.

On the basis of type, the market is segregated into Devices (Microwave energy, Radiofrequency ablation, Thermal Balloon, Cryoablation, Hydrothermal ablation, Hysteroscopy) and Procedures. In 2024, the market was dominated by the devices category. The availability of a number of efficient methods and tools, such as balloon therapy, which involves injecting heated fluid inside a balloon to shatter the endometrium; radiofrequency ablation, which uses high-energy radio waves to destroy the endometrial tissue; and the freezing and smashing of abnormal tissues using an extremely cold fluid or a device called a cryoprobe. Furthermore, the segment demand is largely attributable to advantages including efficacy, product ease, quicker treatment, and affordability when compared to additional endometrial removal equipment. Additionally, doctors' simple access to endometrial removal equipment is catalyzing the market segment's growth in the near future.

Based on end use, the market is divided into Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), and Others. In 2024, the hospitals category held a dominant market share. This importance is related to the increasing number of people who are hospitalized for gynaecological illnesses, which is fueled by hospitals' skilled care and advantageous reimbursement practices. Hospitals have cutting-edge treatment technology, which contributes to this segment's growth. In addition, the thorough handling of possible complications during surgical procedures and the availability of a variety of treatment options on hospital grounds help to increase patient volume in comparison to alternative healthcare environments.

Endometrial Ablation Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Endometrial Ablation. The region's supremacy is fueled by the rising prevalence of gynaecological problems, notable improvements in healthcare infrastructure, and the existence of important industrial companies that can supply state-of-the-art endometrial ablation equipment. In the US, efforts to improve healthcare quality and lower costs have been driven by a steadfast focus on patient outcomes and safety. Significant healthcare spending in the region, which is more than in other parts of the world, adds to the market's upward trajectory.

Furthermore, in the upcoming years, Asia Pacific is anticipated to expand at the greatest CAGR in the endometrial ablation market. The market is expanding as a result of the rising incidence of menorrhagia due to inadequate cleanliness practices and the growing need for cutting-edge and sophisticated endometrial ablation devices. Additionally, the segment may see profitable chances in the years to come due to favourable government regulations, increased investment in the healthcare industry, expanding awareness of irregular uterine bleeding, and growing receptivity to minimally invasive therapies.

Endometrial Ablation Market- Competitive Landscape:

The market for endometrial ablation is very competitive, with a number of major firms vying for market share by providing creative and practical treatments for gynaecological conditions. To improve patient outcomes and increase their market share, these businesses concentrate on product and technology developments. Smith & Nephew Plc, Johnson & Johnson, Hologic, Olympus Corporation, The Cooper Companies, Inc., Karl Storz GmbH & Co. KG and others are some of the leading companies in the market. These businesses use tactics including partnerships, acquisitions, mergers, and collaborations to broaden their product lines and bolster their international footprints. For instance, in March 2023, the EnSeal Endometrial Ablation System, a novel endometrial ablation tool, was introduced by Olympus Corporation. A bipolar radiofrequency ablation tool called the EnSeal Endometrial Ablation System is intended to treat HMB.

Recent Development

February 2023: Hologic Inc.'s NovaSure V5 Global Endometrial Ablation (GEA) has been approved by regulators for use in the Canadian and European markets. The purpose of this innovative medicine is to treat abnormal uterine bleeding (AUB).

January 2023: The NovaSure, a novel endometrial ablation device, was introduced by Hologic. Heavy menstrual bleeding (HMB) can be treated with the NovaSure, a radiofrequency ablation machine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOMETRIAL ABLATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Smith & Nephew Plc
  • Johnson & Johnson
  • Hologic
  • Olympus Corporation
  • The Cooper Companies, Inc.
  • Karl Storz GmbH & Co. KG
  • Medtronic Plc
  • Ethicon, LLC.
  • Boston Scientific Corporation
  • Minerva Surgical, Inc.
  • Richard Wolf GmbH
  • Others

GLOBAL ENDOMETRIAL ABLATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Devices
  • Microwave energy
  • Radiofrequency ablation
  • Thermal Balloon
  • Cryoablation
  • Hydrothermal ablation
  • Hysteroscopy
  • Procedures

GLOBAL ENDOMETRIAL ABLATION MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Others

GLOBAL ENDOMETRIAL ABLATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Endometrial Ablation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Endometrial Ablation Market Snippet by Type
    • 2.1.2. Endometrial Ablation Market Snippet by End Use
    • 2.1.3. Endometrial Ablation Market Snippet by Country
    • 2.1.4. Endometrial Ablation Market Snippet by Region
  • 2.2. Competitive Insights

3. Endometrial Ablation Key Market Trends

  • 3.1. Endometrial Ablation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Endometrial Ablation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Endometrial Ablation Market Opportunities
  • 3.4. Endometrial Ablation Market Future Trends

4. Endometrial Ablation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Endometrial Ablation Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Endometrial Ablation Market Landscape

  • 6.1. Endometrial Ablation Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Endometrial Ablation Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Devices
      • 7.1.2.1. Microwave energy
      • 7.1.2.2. Radiofrequency ablation
      • 7.1.2.3. Thermal Balloon
      • 7.1.2.4. Cryoablation
      • 7.1.2.5. Hydrothermal ablation
      • 7.1.2.6. Hysteroscopy
    • 7.1.3. Procedures

8. Endometrial Ablation Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Clinics
    • 8.1.4. Ambulatory Surgery Centers (ASCs)
    • 8.1.5. Others

9. Endometrial Ablation Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Endometrial Ablation Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Endometrial Ablation Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Endometrial Ablation Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Endometrial Ablation Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Endometrial Ablation Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Endometrial Ablation Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Smith & Nephew Plc
    • 10.2.2. Johnson & Johnson
    • 10.2.3. Hologic
    • 10.2.4. Olympus Corporation
    • 10.2.5. The Cooper Companies, Inc.
    • 10.2.6. Karl Storz GmbH & Co. KG
    • 10.2.7. Medtronic Plc
    • 10.2.8. Ethicon, LLC.
    • 10.2.9. Boston Scientific Corporation
    • 10.2.10. Minerva Surgical, Inc.
    • 10.2.11. Richard Wolf GmbH
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us